PRL and metabolic dysfunction-associated steatotic liver disease: Regarding hepatic lipid metabolism, one clinical study found lower PRL levels in patients with Metabolic Dysfunction-Associated Steatotic liver disease (MASLD) compared with non-MASLD controls.